Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,364,241
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
8,056,307
-
Shares change
-
-36,176
-
Total reported value, excl. options
-
$47,291,256
-
Value change
-
-$192,971
-
Number of buys
-
14
-
Number of sells
-
-13
-
Price
-
$5.87
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q3 2018
39 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q3 2018.
scPharmaceuticals Inc. - Common Stock (SCPH) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,056,307 shares
of 53,364,241 outstanding shares and own 15.1% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3,409,865 shares), RA CAPITAL MANAGEMENT, LLC (2,857,143 shares), AWM Investment Company, Inc. (469,799 shares), BlackRock Inc. (351,149 shares), Alyeska Investment Group, L.P. (230,819 shares), Vanguard Group Inc (205,919 shares), STATE STREET CORP (115,089 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (69,500 shares), NORTHERN TRUST CORP (68,832 shares), and GEODE CAPITAL MANAGEMENT, LLC (50,285 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.